ivabradine has been researched along with digoxin in 18 studies
| Studies (ivabradine) | Trials (ivabradine) | Recent Studies (post-2010) (ivabradine) | Studies (digoxin) | Trials (digoxin) | Recent Studies (post-2010) (digoxin) |
|---|---|---|---|---|---|
| 1,143 | 197 | 833 | 11,483 | 958 | 1,289 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (5.56) | 29.6817 |
| 2010's | 13 (72.22) | 24.3611 |
| 2020's | 4 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Boos, C; Gorman, S | 1 |
| Akchurin, RS; Chernova, NA; Erastova, NV; Grishin, IR; Karpov, IuA; Latypov, RS; Lopukhova, VV; Mareev, IuV; Saidova, MA; Sapel'nikov, OV | 1 |
| Alabd, A; Gamal, A; Rayan, M; Tawfik, M | 1 |
| Castagno, D; Claggett, B; McMurray, J; Petrie, MC | 1 |
| Drożdż, J; Filipiak, KJ; Grajek, S; Kasprzak, JD; Opolski, G; Rynkiewicz, A; Stępińska, J; Tykarski, A; Wożakowska Kapłon, B | 1 |
| Lim, WY; Woldman, S | 1 |
| Eriksson, U; Müller-Edenborn, B | 1 |
| Enseleit, F; Flammer, AJ; Naegele, M; Ruschitzka, F | 1 |
| Korabathina, R; Wojnowich, K | 1 |
| Hensey, M; O'Neill, J | 1 |
| Adhyaru, B; Raj, L | 1 |
| Wu, A | 1 |
| Andrey, JL; Aranda, R; Egido, J; Gomez, F; Gomez, R; Guzman, M; Pedrosa, MJ; Romero, SP | 1 |
| Asselbergs, FW; Bots, SH; Day, D; den Ruijter, HM; Eikendal, ALM; Groepenhoff, F; Miller, VM; Regitz-Zagrosek, V; Rochon, PA; Tannenbaum, C | 1 |
| Arias, MÁ; Arribas, F; Fontenla, A; Gómez de la Cámara, A; López-Gil, M; Matía-Francés, R; Mejía-Martínez, E; Miracle-Blanco, Á; Montilla, I; Pastor-Fuentes, A; Rey-Blas, JR; Salgado-Aranda, R; Tamargo-Menéndez, J; Toquero-Ramos, J | 1 |
| Bosco-Lévy, P; Droz-Perroteau, C; Favary, C; Jové, J; Lassalle, R; Moore, N | 1 |
| Chang, HY; Chen, CH; Lan, WR; Lee, YH; Liao, FC; Lin, SI; Liu, PY; Tsai, CT; Wu, YJ | 1 |
| Bueno, H; Fontenla, A; García-Fernandez, FJ; López-Gil, M; Matía, R; Mejía, E; Miracle, A; Montilla, I; Rajjoub, EA; Rey, JR; Salgado, R; Tamargo, J; Toquero, J | 1 |
9 review(s) available for ivabradine and digoxin
| Article | Year |
|---|---|
Pharmacological management of chronic heart failure: old drugs, new drugs and new indications.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Cardiovascular Agents; Chronic Disease; Digoxin; Drug Combinations; Heart Failure; Heart Failure, Systolic; Humans; Hydralazine; Isosorbide Dinitrate; Ivabradine; Mineralocorticoid Receptor Antagonists | 2013 |
[Heart failure - up to date].
Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Cardiotonic Agents; Digoxin; Diuretics; Drug Therapy, Combination; Evidence-Based Medicine; Heart Failure; Hemodynamics; Humans; Ivabradine; Mineralocorticoid Receptor Antagonists; Patient Readmission; Quality of Life; Survival Rate; Ventricular Dysfunction, Left | 2013 |
Medical therapy of heart failure with reduced ejection fraction: current evidence and new developments.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Cardiotonic Agents; Cardiovascular Agents; Digoxin; Diuretics; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Ivabradine; Mineralocorticoid Receptor Antagonists; Neprilysin; Stroke Volume; Vasodilator Agents | 2016 |
Heart Failure Update: Outpatient Management.
Topics: Adrenergic beta-Antagonists; Aged; Ambulatory Care; Aminobutyrates; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Biphenyl Compounds; Cardiac Resynchronization Therapy; Cardiotonic Agents; Cardiovascular Agents; Diet, Sodium-Restricted; Digoxin; Diuretics; Drug Combinations; Exercise Therapy; Fatty Acids, Omega-3; Female; Heart Failure; Heart Transplantation; Hospice Care; Humans; Ivabradine; Mineralocorticoid Receptor Antagonists; Tetrazoles; Valsartan; Vasodilator Agents | 2016 |
Is Heart Rate a Norepiphenomenon in Heart Failure?
Topics: Adrenergic Antagonists; Amiodarone; Benzazepines; Depression, Chemical; Digoxin; Evidence-Based Medicine; Heart Failure; Heart Rate; Humans; Ivabradine | 2016 |
An evidence-based review of recent advances in therapy for heart failure with reduced ejection fraction (HFrEF).
Topics: Adrenergic beta-Antagonists; American Heart Association; Amides; Aminobutyrates; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Antihypertensive Agents; Atrial Natriuretic Factor; Benzazepines; Biphenyl Compounds; Calcium Channel Blockers; Cardiology; Cardiotonic Agents; Cardiovascular Agents; Digoxin; Diuretics; Drug Combinations; Erythropoietin; Evidence-Based Medicine; Fumarates; Heart Failure; Hematinics; Humans; Hydralazine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Iron; Isosorbide Dinitrate; Ivabradine; Mineralocorticoid Receptor Antagonists; Peptide Fragments; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Societies, Medical; Stroke Volume; Tetrazoles; United States; Valsartan; Vasodilator Agents | 2016 |
Heart Failure.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Cardiac Rehabilitation; Cardiovascular Agents; Coronary Artery Disease; Defibrillators, Implantable; Diabetes Complications; Diagnostic Techniques, Cardiovascular; Digoxin; Diuretics; Heart Failure; Hospitalization; Humans; Hydralazine; Hypertension; Isosorbide Dinitrate; Ivabradine; Life Style; Mineralocorticoid Receptor Antagonists; Palliative Care; Primary Prevention; Referral and Consultation; Risk Factors | 2018 |
Adverse Drug Reactions to Guideline-Recommended Heart Failure Drugs in Women: A Systematic Review of the Literature.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Cardiovascular Agents; Digoxin; Drug-Related Side Effects and Adverse Reactions; Female; Heart Failure; Humans; Ivabradine; Male; Mineralocorticoid Receptor Antagonists; Mortality; Practice Guidelines as Topic; Research Design; Research Report; Sex Distribution; Sex Factors; Stroke Volume | 2019 |
Effect of Reducing Heart Rate on Outcomes in Patients With Reduced Ejection Fraction.
Topics: Cardiovascular Agents; Digoxin; Heart Failure; Heart Rate; Humans; Ivabradine; Stroke Volume; Tachycardia | 2021 |
3 trial(s) available for ivabradine and digoxin
| Article | Year |
|---|---|
Ivabradine, a novel heart rate slower: is it a sword of double blades in patients with idiopathic dilated cardiomyopathy?
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Benzazepines; Carbazoles; Cardiomyopathy, Dilated; Cardiotonic Agents; Carvedilol; Digoxin; Diuretics; Drug Therapy, Combination; Echocardiography; Electrocardiography; Electrocardiography, Ambulatory; Female; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Propanolamines; Prospective Studies; Spironolactone; Vasodilator Agents; Ventricular Premature Complexes | 2011 |
Ivabradine for chronic heart rate control in persistent atrial fibrillation. Design of the BRAKE-AF project.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiovascular Agents; Digoxin; Equivalence Trials as Topic; Heart Rate; Humans; Ivabradine; Treatment Outcome | 2020 |
Ivabradine for controlling heart rate in permanent atrial fibrillation: A translational clinical trial.
Topics: Adrenergic beta-Antagonists; Atrial Fibrillation; Digoxin; Heart Rate; Humans; Ivabradine | 2023 |
6 other study(ies) available for ivabradine and digoxin
| Article | Year |
|---|---|
Ivabradine in heart failure: what about digoxin?
Topics: Adrenergic beta-Antagonists; Benzazepines; Cardiotonic Agents; Confounding Factors, Epidemiologic; Digoxin; Drug Therapy, Combination; Heart Failure; Humans; Ivabradine | 2008 |
[Application of cardiac resynchronization therapy and ivabradine in a patient with chronic heart failure].
Topics: Benzazepines; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiovascular Agents; Digoxin; Diuretics; Echocardiography; Electrocardiography; Furosemide; Heart Atria; Heart Failure; Heart Rate; Heart Ventricles; Humans; Ivabradine; Male; Middle Aged; Myocardial Infarction; Spironolactone; Treatment Outcome | 2010 |
Should we SHIFT our thinking about digoxin? Observations on ivabradine and heart rate reduction in heart failure.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzazepines; Digoxin; Female; Heart Failure; Humans; Ivabradine; Kaplan-Meier Estimate; Male; Middle Aged; Randomized Controlled Trials as Topic; Retrospective Studies; Stroke Volume; Treatment Outcome; Ventricular Dysfunction, Left | 2012 |
[Optimum heart rate - the current goal of cardiovascular therapy. Position statement of the Polish Cardiac Society Working Group on Cardiovascular Drug Therapy].
Topics: Adrenergic beta-Agonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzazepines; Digoxin; Diltiazem; Heart Diseases; Heart Rate; Humans; Hypertension; Ivabradine; Verapamil | 2012 |
Prognosis of heart failure treated with digoxin or with ivabradine: A cohort study in the community.
Topics: Adrenergic beta-Antagonists; Aged; Cardiotonic Agents; Cardiovascular Agents; Cohort Studies; Comorbidity; Digoxin; Female; Heart Failure; Hospitalization; Humans; Ivabradine; Male; Patient Readmission; Prognosis; Stroke Volume; Treatment Outcome | 2018 |
Pharmacological treatment patterns in heart failure: a population-based cohort study.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Agents; Clinical Protocols; Cohort Studies; Digoxin; Diuretics; Drug Substitution; Female; France; Heart Failure; Hospitalization; Humans; Ivabradine; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Time Factors | 2020 |